Literature DB >> 28105273

Investigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLA2 Inhibitor.

Nicholas D Measom1, Kenneth D Down2, David J Hirst2, Craig Jamieson3, Eric S Manas4, Vipulkumar K Patel2, Don O Somers2.   

Abstract

We describe the incorporation of a bicyclo[1.1.1]pentane moiety within two known LpPLA2 inhibitors to act as bioisosteric phenyl replacements. An efficient synthesis to the target compounds was enabled with a dichlorocarbene insertion into a bicyclo[1.1.0]butane system being the key transformation. Potency, physicochemical, and X-ray crystallographic data were obtained to compare the known inhibitors to their bioisosteric counterparts, which showed the isostere was well tolerated and positively impacted on the physicochemical profile.

Entities:  

Keywords:  LpPLA2; bicyclo[1.1.1]pentane; bioisostere; cardiovascular disease; darapladib; physicochemical

Year:  2016        PMID: 28105273      PMCID: PMC5238484          DOI: 10.1021/acsmedchemlett.6b00281

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  40 in total

1.  Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development.

Authors:  Robert L Wilensky; Yi Shi; Emile R Mohler; Damir Hamamdzic; Mark E Burgert; Jun Li; Anthony Postle; Robert S Fenning; James G Bollinger; Bryan E Hoffman; Daniel J Pelchovitz; Jisheng Yang; Rosanna C Mirabile; Christine L Webb; LeFeng Zhang; Ping Zhang; Michael H Gelb; Max C Walker; Andrew Zalewski; Colin H Macphee
Journal:  Nat Med       Date:  2008-09-21       Impact factor: 53.440

2.  Synthesis and biological evaluation of 2-(3'-(1H-tetrazol-5-yl) bicyclo[1.1.1]pent-1-yl)glycine (S-TBPG), a novel mGlu1 receptor antagonist.

Authors:  G Costantino; K Maltoni; M Marinozzi; E Camaioni; L Prezeau; J P Pin; R Pellicciari
Journal:  Bioorg Med Chem       Date:  2001-02       Impact factor: 3.641

3.  Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events.

Authors:  Sotirios Tsimikas; Ziad Mallat; Philippa J Talmud; John J P Kastelein; Nicholas J Wareham; Manjinder S Sandhu; Elizabeth R Miller; Joelle Benessiano; Alain Tedgui; Joseph L Witztum; Kay-Tee Khaw; S Matthijs Boekholdt
Journal:  J Am Coll Cardiol       Date:  2010-09-14       Impact factor: 24.094

4.  Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.

Authors:  Marc S Sabatine; David A Morrow; Michelle O'Donoghue; Kathleen A Jablonksi; Madeline Murguia Rice; Scott Solomon; Yves Rosenberg; Michael J Domanski; Judith Hsia
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-31       Impact factor: 8.311

5.  Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.

Authors:  U P Steinbrecher; P H Pritchard
Journal:  J Lipid Res       Date:  1989-03       Impact factor: 5.922

6.  Crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis.

Authors:  Uttamkumar Samanta; Brian J Bahnson
Journal:  J Biol Chem       Date:  2008-09-10       Impact factor: 5.157

7.  Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

Authors:  Michelle L O'Donoghue; Eugene Braunwald; Harvey D White; Dylan P Steen; Mary Ann Lukas; Elizabeth Tarka; P Gabriel Steg; Judith S Hochman; Christoph Bode; Aldo P Maggioni; KyungAh Im; Jennifer B Shannon; Richard Y Davies; Sabina A Murphy; Sharon E Crugnale; Stephen D Wiviott; Marc P Bonaca; David F Watson; W Douglas Weaver; Patrick W Serruys; Christopher P Cannon; Dylan L Steen
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

8.  Escape from flatland: increasing saturation as an approach to improving clinical success.

Authors:  Frank Lovering; Jack Bikker; Christine Humblet
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

Review 9.  Phospholipase A2 biochemistry.

Authors:  John E Burke; Edward A Dennis
Journal:  Cardiovasc Drugs Ther       Date:  2008-10-18       Impact factor: 3.727

10.  Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.

Authors:  Stefan Kiechl; Johann Willeit; Manuel Mayr; Brigitte Viehweider; Martin Oberhollenzer; Florian Kronenberg; Christian J Wiedermann; Sabine Oberthaler; Qingbo Xu; Joseph L Witztum; Sotirios Tsimikas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-05-31       Impact factor: 8.311

View more
  17 in total

1.  Reactions of 2-Aryl-1,3-Dithianes and [1.1.1]Propellane.

Authors:  Nisalak Trongsiriwat; Youge Pu; Yexenia Nieves-Quinones; Russell A Shelp; Marisa C Kozlowski; Patrick J Walsh
Journal:  Angew Chem Int Ed Engl       Date:  2019-08-07       Impact factor: 15.336

Review 2.  Lipoprotein-associated phospholipase A2: The story continues.

Authors:  Fubao Huang; Kai Wang; Jianhua Shen
Journal:  Med Res Rev       Date:  2019-05-29       Impact factor: 12.944

3.  One-Pot Synthesis of Strain-Release Reagents from Methyl Sulfones.

Authors:  Myunggi Jung; Vincent N G Lindsay
Journal:  J Am Chem Soc       Date:  2022-03-14       Impact factor: 16.383

4.  Phenyl bioisosteres in medicinal chemistry: discovery of novel γ-secretase modulators as a potential treatment for Alzheimer's disease.

Authors:  H Ratni; K Baumann; P Bellotti; X A Cook; L G Green; T Luebbers; M Reutlinger; A F Stepan; W Vifian
Journal:  RSC Med Chem       Date:  2021-04-12

Review 5.  Put a ring on it: application of small aliphatic rings in medicinal chemistry.

Authors:  Matthias R Bauer; Paolo Di Fruscia; Simon C C Lucas; Iacovos N Michaelides; Jennifer E Nelson; R Ian Storer; Benjamin C Whitehurst
Journal:  RSC Med Chem       Date:  2021-01-07

6.  An intramolecular coupling approach to alkyl bioisosteres for the synthesis of multisubstituted bicycloalkyl boronates.

Authors:  Yangyang Yang; Jet Tsien; Jonathan M E Hughes; Byron K Peters; Rohan R Merchant; Tian Qin
Journal:  Nat Chem       Date:  2021-09-28       Impact factor: 24.427

7.  Electrophilic Activation of [1.1.1]Propellane for the Synthesis of Nitrogen-Substituted Bicyclo[1.1.1]pentanes.

Authors:  Sarah Livesley; Alistair J Sterling; Craig M Robertson; William R F Goundry; James A Morris; Fernanda Duarte; Christophe Aïssa
Journal:  Angew Chem Int Ed Engl       Date:  2021-11-26       Impact factor: 16.823

8.  Divergent Strain-Release Amino-Functionalization of [1.1.1]Propellane with Electrophilic Nitrogen-Radicals.

Authors:  Ji Hye Kim; Alessandro Ruffoni; Yasair S S Al-Faiyz; Nadeem S Sheikh; Daniele Leonori
Journal:  Angew Chem Int Ed Engl       Date:  2020-02-26       Impact factor: 15.336

9.  Bridging and Conformational Control of Porphyrin Units through Non-Traditional Rigid Scaffolds.

Authors:  Nitika Grover; Gemma M Locke; Keith J Flanagan; Michael H R Beh; Alison Thompson; Mathias O Senge
Journal:  Chemistry       Date:  2020-01-21       Impact factor: 5.236

10.  Synthesis and applications of highly functionalized 1-halo-3-substituted bicyclo[1.1.1]pentanes.

Authors:  Dimitri F J Caputo; Carlos Arroniz; Alexander B Dürr; James J Mousseau; Antonia F Stepan; Steven J Mansfield; Edward A Anderson
Journal:  Chem Sci       Date:  2018-05-21       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.